Dean F Bajorin: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Prognostic factors in patients with metastatic malignant melanoma: A multivariate analysis

Matthew N. Sirott, Dean F. Bajorin, George Y. C. Wong, Yue Tao, Paul B. Chapman, Mary Agnes Templeton, Alan N. Houghton

Journal:

Year:

1993

Language:

english

File:

PDF, 780 KB

english, 1993

2

New Data, New Paradigms for Treating Prostate Cancer Patients—VI: Novel Hormonal Therapy Approaches

Robert Dreicer, Dean F. Bajorin, David G. McLeod, Daniel P. Petrylak, Judd W. Moul

Journal:

Year:

2011

Language:

english

File:

PDF, 413 KB

english, 2011

3

Immune Responses Detected in Urothelial Carcinoma Patients After Vaccination With NY-ESO-1 Protein Plus BCG and GM-CSF

Sharma, Padmanee, Bajorin, Dean F., Jungbluth, Achim A., Herr, Harry, Old, Lloyd J., Gnjatic, Sacha

Journal:

Journal of Immunotherapy

Year:

2008

Language:

english

File:

PDF, 584 KB

english, 2008

4

Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma

Paul M. Dodd, John A. McCaffrey, Madhu Mazumdar, Howard Scher, Vaia Vlamis, Geralyn Higgins, Harry Herr, Dean F. Bajorin

Journal:

Year:

1999

Language:

english

File:

PDF, 78 KB

english, 1999

5

Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract : Final report of a Phase II trial evaluating two dosing schedules

Dean F. Bajorin, John A. McCaffrey, Paul M. Dodd, Susan Hilton, Madhu Mazumdar, W. Kevin Kelly, Harry Herr, Howard I. Scher, Evelyn Icasiano, Geralyn Higgins

Journal:

Year:

2000

Language:

english

File:

PDF, 88 KB

english, 2000

6

Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors

Robert J. Motzer, Karen Cooper, Nancy L. Geller, David G. Pfister, Shiow-Yun Lin, Dean Bajorin, Howard I. Scher, Harry Herr, William Fair, Michael Morse, Pramod Sogani, Willet Whitmore, George J. Bosl

Journal:

Year:

1990

Language:

english

File:

PDF, 536 KB

english, 1990

7

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors

Robert J. Motzer, Karen Cooper, Nancy L. Geller, Dean F. Bajorin, Ethan Dmitrovsky, Harry Herr, Michael Morse, William Fair, Pramod Sogani, Paul Russo, George J. Bosl

Journal:

Year:

1990

Language:

english

File:

PDF, 537 KB

english, 1990

8

Two-drug therapy in patients with metastatic germ cell tumors

Dean F. Bajorin, Nancy L. Geller, Steven F. Weisen, George J. Bosl

Journal:

Year:

1991

Language:

english

File:

PDF, 475 KB

english, 1991

9

Serum tumor markers and patient allocation to good-risk and poor-risk clinical trials in patients with germ cell tumors

George J. Bosl, Nancy L. Geller, Dean Bajorin

Journal:

Year:

1991

Language:

english

File:

PDF, 552 KB

english, 1991

10

A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma

Thomas A. Steffens, Dean F. Bajorin, Paul B. Chapman, David R. Lovett, Beverly V. Cody-Johnson, Mary Agnes Templeton, Robert T. Heelan, George Y. Wong, Carol S. Portlock, Herbert F. Oettgen, Alan N. H

Journal:

Year:

1991

Language:

english

File:

PDF, 831 KB

english, 1991

11

Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors

Andrew D. Seidman, Howard I. Scher, M. H. Heinemann, Dean F. Bajorin, Cora N. Sternberg, D. David Dershaw, Mary Silverberg, George J. Bosl

Journal:

Year:

1991

Language:

english

File:

PDF, 439 KB

english, 1991

12

Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trial

Robert J. Motzer, Ethan Dmitrovsky, Wilson H. Miller Jr., William P. Tong, Dean F. Bajorin, Howard I. Scher, George J. Bosl

Journal:

Year:

1993

Language:

english

File:

PDF, 523 KB

english, 1993

13

Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy

Barbara A. Murphy, Robert J. Motzer, Madhu Mazumdar, Vaia Vlamis, Jerome Nisselbaum, Dean Bajorin, George J. Bosl

Journal:

Year:

1994

Language:

english

File:

PDF, 655 KB

english, 1994

14

Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors

Armen G. Aprikian, Harry W. Herr, Dean F. Bajorin, George J. Bosl

Journal:

Year:

1994

Language:

english

File:

PDF, 606 KB

english, 1994

15

Phase iii randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma

Teresa Murray Law, Robert J. Motzer, Madhu Mazumdar, Kenneth W. Sell, Philip Walther, Michael O'Connell, Amanullah Khan, Vaia Vlamis, Nicholas J. Vogelzang, Dean F. Bajorin

Journal:

Year:

1995

Language:

english

File:

PDF, 723 KB

english, 1995

16

Overview of bladder cancer trials in the Cancer and Leukemia Group B

Eric J. Small, Susan Halabi, Guido Dalbagni, Raj Pruthi, George Phillips, Martin Edelman, Dean Bajorin

Journal:

Year:

2003

Language:

english

File:

PDF, 110 KB

english, 2003

17

Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function

Matthew D. Galsky, Alexia Iasonos, Svetlana Mironov, Joseph Scattergood, Mary G. Boyle, Dean F. Bajorin

Journal:

Year:

2007

Language:

english

File:

PDF, 108 KB

english, 2007

18

The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor

Atreya Dash, Brett S. Carver, Jason Stasi, Dean F. Bajorin, Robert J. Motzer, George J. Bosl, Joel Sheinfeld

Journal:

Year:

2008

Language:

english

File:

PDF, 111 KB

english, 2008

19

Advanced bladder cancer: Status of first-line chemotherapy and the search for active agents in the second-line setting

David J. Gallagher, Matthew I. Milowsky, Dean F. Bajorin

Journal:

Year:

2008

Language:

english

File:

PDF, 113 KB

english, 2008

20

A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder : A retrospective experience

Atreya Dash, Joseph A. Pettus IV, Harry W. Herr, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Paul Russo, Mary G. Boyle, Matthew I. Milowsky, Dean F. Bajorin

Journal:

Year:

2008

Language:

english

File:

PDF, 113 KB

english, 2008

21

Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinoma

David J. Gallagher, Matthew I. Milowsky, Alexia Iasonos, Fernando C. Maluf, Paul Russo, Guido Dalbagni, Machele S. Donat, Mary G. Boyle, Junting Zheng, Jamie Riches, Dean F. Bajorin

Journal:

Year:

2009

Language:

english

File:

PDF, 209 KB

english, 2009

22

Evaluation of lymph node counts in primary retroperitoneal lymph node dissection

R. Houston Thompson, Brett S. Carver, George J. Bosl, Dean Bajorin, Robert Motzer, Darren Feldman, Victor E. Reuter, Joel Sheinfeld

Journal:

Year:

2010

Language:

english

File:

PDF, 183 KB

english, 2010

23

Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design

Darren R. Feldman, Sujata Patil, Michael J. Trinos, Maryann Carousso, Michelle S. Ginsberg, Joel Sheinfeld, Dean F. Bajorin, George J. Bosl, Robert J. Motzer

Journal:

Year:

2012

Language:

english

File:

PDF, 817 KB

english, 2012

24

Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients

Iman Osman, Melissa Kang, Andy Lee, Fang-Ming Deng, David Polsky, Maryann Mikhail, Caroline Chang, Dexter A. David, Nandita Mitra, Xue-Ru Wu, Tung-Tien Sun, Dean F. Bajorin

Journal:

International Journal of Cancer

Year:

2004

Language:

english

File:

PDF, 141 KB

english, 2004

25

Bladder cancer: advances in biology and treatment

George J. Bosl, William R. Fair, Harry W. Herr, Dean F. Bajorin, Guido Dalbagni, Alvaro S. Sarkis, Victor E. Reuter, Carlos Cordon-Cardo, Joel Sheinfeld, Howard I. Scher

Journal:

Critical Reviews in Oncology/Hematology

Year:

1994

Language:

english

File:

PDF, 6.13 MB

english, 1994

26

Phase II trial of carboplatin in patients with advanced melanoma

Ephraim S. Casper, Dean Bajorin

Journal:

Investigational New Drugs

Year:

1990

Language:

english

File:

PDF, 331 KB

english, 1990

27

Decompression of epidural metastases from germ cell tumors with chemotherapy

Karen Cooper, Dean Bajorin, William Shapiro, George Krol, Gordon Sze, George J. Bosl

Journal:

Journal of Neuro-Oncology

Year:

1990

Language:

english

File:

PDF, 498 KB

english, 1990

28

Phase II trial of N-methylformamide in patients with metastatic melanoma

Omar Eton, Dean F. Bajorin, Ephraim S. Casper, Alan N. Houghton

Journal:

Investigational New Drugs

Year:

1991

Language:

english

File:

PDF, 276 KB

english, 1991

29

Phase II trial of cisplatin and etoposide in patients with metastatic melanoma

Omar Eton, Dean F. Bajorin, Paul B. Chapman, Beverly V. Cody, Alan N. Houghton

Journal:

Investigational New Drugs

Year:

1991

Language:

english

File:

PDF, 195 KB

english, 1991

30

Phase II trial of Didemnin B in patients with advanced renal cell carcinoma

Robert Motzer, Howard Scher, Dean Bajorin, Cora Sternberg, George J. Bosl

Journal:

Investigational New Drugs

Year:

1990

Language:

english

File:

PDF, 115 KB

english, 1990

31

Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumors

Heidi Sonya Puc, Dean F. Bajorin, George J. Bosl, Alison Amsterdam, Robert J. Motzer

Journal:

Investigational New Drugs

Year:

1995

Language:

english

File:

PDF, 171 KB

english, 1995

32

A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer

David G. Pfister, Dean Bajorin, Robert J. Motzer, Howard Scher, Carl Louison, Louis Harrison, Jatin Shah, Elliot Strong, George Bosl

Journal:

Investigational New Drugs

Year:

1993

Language:

english

File:

PDF, 269 KB

english, 1993

33

Immunotherapy with monoclonal antibodies in metastatic melanoma

Thomas A. Steffens, Dean F. Bajorin, Alan N. Houghton

Journal:

World Journal of Surgery

Year:

1992

Language:

english

File:

PDF, 1.24 MB

english, 1992

34

Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma

Matthew D. Galsky, Svetlana Mironov, Alexia Iasonos, Joseph Scattergood, Mary G. Boyle, Dean F. Bajorin

Journal:

Investigational New Drugs

Year:

2007

Language:

english

File:

PDF, 182 KB

english, 2007

35

A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102

George K. Philips, Susan Halabi, Ben L. Sanford, Dean Bajorin, Eric J. Small, Cancer, Leukaemia Group B

Journal:

BJU International

Year:

2008

Language:

english

File:

PDF, 116 KB

english, 2008

36

Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer

Matthew I. Milowsky, Walter M. Stadler, Dean F. Bajorin

Journal:

BJU International

Year:

2008

Language:

english

File:

PDF, 105 KB

english, 2008

37

Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications

Satish K. Tickoo, Matthew I. Milowsky, Nitin Dhar, Maria E. Dudas, David J. Gallagher, Hikmat Al-Ahmadie, Anuradha Gopalan, Samson W. Fine, Nicole Ishill, Dean F. Bajorin, Victor E. Reuter

Journal:

BJU International

Year:

2011

Language:

english

File:

PDF, 592 KB

english, 2011

38

Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy

Matthew G. Kaag, Matthew I. Milowsky, Guido Dalbagni, R. Houston Thompson, Darren Katz, Victor E. Reuter, Harry W. Herr, Dean Bajorin, Bernard H. Bochner

Journal:

BJU International

Year:

2011

Language:

english

File:

PDF, 140 KB

english, 2011

39

Phase II Trial of Pyrazoloacridine in Patients with Cisplatin-Refractory Germ Cell Tumors

Jacqueline Vuky, John McCaffrey, Michelle Ginsberg, Tania Mariani, Dean F. Bajorin, George J. Bosl, Robert J. Motzer

Journal:

Investigational New Drugs

Year:

2000

Language:

english

File:

PDF, 37 KB

english, 2000

40

Phase II Trial of Pyrazoloacridine as Second-Line Therapy for Patients with Unresectable or Metastatic Transitional Cell Carcinoma

Paul M. Dodd, John A. McCaffrey, Madhu Mazumdar, Evelyn Icasiano, Geralyn Higgins, Harry Herr, Dean F. Bajorin

Journal:

Investigational New Drugs

Year:

2000

Language:

english

File:

PDF, 50 KB

english, 2000

41

Phase II Trial of Temozolomide in Patients with Cisplatin-Refractory Germ Cell Tumors

G. Varuni Kondagunta, Jennifer Bacik, Lawrence Schwartz, Joel Sheinfeld, Dean Bajorin, Jacqueline Vuky, Stephanie Marion, Madhu Mazumdar, George J. Bosl, Robert J. Motzer

Journal:

Investigational New Drugs

Year:

2004

Language:

english

File:

PDF, 41 KB

english, 2004

42

Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate

Maurie Markman, Robert D'Acquisto, Nicholas Iannotti, Mark Kris, Thomas Hakes, Dean Bajorin, George Bosl, Bonnie Reichman, Ephraim Casper, Gordon Magill, Amy Budnick

Journal:

Journal of Cancer Research and Clinical Oncology

Year:

1991

Language:

english

File:

PDF, 563 KB

english, 1991

43

Retrospective Analysis of Satraplatin in Patients with Metastatic Urothelial Cancer Refractory to Standard Platinum-Based Chemotherapy

Matthew D. Galsky, Sonia Seng, Luis H. Camacho, Elena G. Chiorean, Daniel Mulkerin, David S. Hong, William K. Oh, Dean F. Bajorin

Journal:

Clinical Genitourinary Cancer

Year:

2011

Language:

english

File:

PDF, 208 KB

english, 2011

44

The Evolution of Bladder Cancer Treatment: Improvements in Clinical Management, Enhanced Clinical Outcomes, and Targeting Newly Identified Molecular Alterations

Dean F. Bajorin

Journal:

Seminars in Oncology

Year:

2007

Language:

english

File:

PDF, 57 KB

english, 2007

45

Arsenic Trioxide in Recurrent Urothelial Cancer: A Cancer and Leukemia Group B Phase II Trial (CALGB 99903)

Dean F. Bajorin, Susan Halabi, Eric Small

Journal:

Clinical Genitourinary Cancer

Year:

2009

Language:

english

File:

PDF, 108 KB

english, 2009

46

Prospective Trial of Ifosfamide, Paclitaxel, and Cisplatin in Patients with Advanced Non-transitional Cell Carcinoma of the Urothelial Tract

Matthew D. Galsky, Alexia Iasonos, Svetlana Mironov, Joseph Scattergood, S. Machele Donat, Bernard H. Bochner, Harry W. Herr, Paul Russo, Mary G. Boyle, Dean F. Bajorin

Journal:

Year:

2007

Language:

english

File:

PDF, 102 KB

english, 2007

47

The Total Number of Retroperitoneal Lymph Nodes Resected Impacts Clinical Outcome After Chemotherapy for Metastatic Testicular Cancer

Brett S. Carver, Angel M. Cronin, Scott Eggener, Caroline J. Savage, Robert J. Motzer, Dean Bajorin, George J. Bosl, Joel Sheinfeld

Journal:

Year:

2010

Language:

english

File:

PDF, 271 KB

english, 2010

48

Contemporary Lymph Node Counts During Primary Retroperitoneal Lymph Node Dissection

R. Houston Thompson, Brett S. Carver, George J. Bosl, Dean Bajorin, Robert Motzer, Darren R. Feldman, Victor E. Reuter, Joel Sheinfeld

Journal:

Year:

2011

Language:

english

File:

PDF, 224 KB

english, 2011

49

Body Mass Index Is Associated With Higher Lymph Node Counts During Retroperitoneal Lymph Node Dissection

R. Houston Thompson, Brett S. Carver, George J. Bosl, Dean Bajorin, Robert Motzer, Darren Feldman, Victor E. Reuter, Joel Sheinfeld

Journal:

Year:

2012

Language:

english

File:

PDF, 226 KB

english, 2012

50

Clinical Impact of Residual Extraretroperitoneal Masses in Patients With Advanced Nonseminomatous Germ Cell Testicular Cancer

Timothy A. Masterson, Bobby Shayegan, Brett S. Carver, Dean F. Bajorin, Darren R. Feldman, Robert J. Motzer, George J. Bosl, Joel Sheinfeld

Journal:

Year:

2012

Language:

english

File:

PDF, 266 KB

english, 2012

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски